After the Autumn 2024 budget was announced, MTI reached out to contacts in MedTech for comment on what it would mean for the industry, as well as being inundated with comments from the wider life sciences sector.
Andreas Montag, business development director Medical at Sumitomo (SHI) Demag and regional sales director Andrew Sargisson discuss what’s driving the growth in the cleanroom markets.
John Kawola, chief executive officer-global operations of Boston Micro Fabrication (BMF), discusses how 3D Printing is driving innovation across medicine.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, flags the regulations that herald a new Post-Market Surveillance regime for Medical Devices in the UK.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, highlights a new government strategy that feature the potential economic contribution of the life sciences.
Chris Whitehouse, a political consultant and expert on MedTech policy and regulation, highlights a new government strategy to ensure that in future MedTech is part of the circular, not linear economy, and that products are re-used or recycled.
